Answers are grounded in this paper and cite their sources.
This perspective demonstrates how multiomics and machine learning improve drug development and clinical decision-making in antimicrobial resistance.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Arun et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: